Moody National Bank Trust Division Grifols Sa Transaction History

Moody National Bank Trust Division

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$10.21 - $15.27 $229,316 - $342,964	-22,460 Closed	0 $0
Q3 2021 Oct 07, 2021	SELL	$14.07 - $17.3 $2,194 - $2,698	-156 Reduced 0.69%	22,460 $328,000
Q4 2020 Mar 04, 2021	BUY	$16.86 - $19.67 $2,444 - $2,852	145 Added 0.65%	22,616 $417,000
Q3 2020 Oct 08, 2020	SELL	$15.4 - $20.16 $2,371 - $3,104	-154 Reduced 0.68%	22,471 $390,000
Q2 2019 Jul 22, 2019	SELL	$17.59 - $21.1 $1,882 - $2,257	-107 Reduced 0.47%	22,625 $477,000
Q1 2019 Apr 11, 2019	BUY	$18.01 - $20.11 $4,898 - $5,469	272 Added 1.21%	22,732 $457,000
Q4 2018 Jan 07, 2019	BUY	$17.44 - $21.53 $14,126 - $17,439	810 Added 3.74%	22,460 $412,000
Q3 2018 Oct 31, 2018	BUY	$19.97 - $21.96 $432,350 - $475,434	21,650 New	21,650 $463,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

Stay updated on Moody National Bank Trust Division with notifications on news.